In a previous study, we showed that pentraxin-3 (PTX3) can modulate the immunoflogosis in the ccRCC microenvironment through the activation of the classical pathway of the complement system (C1q) and the release of proangiogenic factors (C3a and C5a) [19]. The gene discussed is C3; the disease is nonpapillary renal cell carcinoma.